Advanced Proteome Therapeutics Corporation APTCF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score

42/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Advanced Proteome Therapeutics Corporation (APTCF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 38/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

42/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✗

HEALTH

100/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

28/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — APTCF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2014	$-0.12	$0.00	$-1.15M	-
2015	$-0.08	$0.00	$-886.86K	-
2016	$-0.08	$0.00	$-867K	-
2017	$-0.06	$0.00	$-722K	-
2018	$-0.05	$0.00	$-745K	-
2019	$-0.02	$0.00	$-333K	-
2020	$-0.02	$0.00	$-450.64K	-
2021	$-0.06	$0.00	$-1.83M	-
2022	$0.01	$0.00	$759.62K	-
2023	$0.00	$0.00	$0.00	-